|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Revenue | |
| Cost of sales | |
| Gross profit | |
| Operating expenses | |
| Research and development | |
| Selling, general and administrative | |
| (Gain) loss on disposal of fixed assets | |
| Total operating expenses | |
| Loss from operations | |
| Other expense | |
| Change in fair value of warrant liability | |
| Loss on extinguishment of debt | |
| Interest income | |
| Interest expense, net | |
| Gain from settlement of contingent liabilities | |
| Other income (expense), net | |
| Total other expense, net | |
| Loss before income tax benefit | |
| Income tax benefit | |
| Net loss and comprehensive loss | |
| Less: Accretion of dividends | |
| Series C Preferred Stock | |
| Series D-1 Preferred Stock | |
| Series D-3 Preferred Stock | |
| Net loss attributable to common shareholders, basic | |
| Net loss available to common stockholders, diluted | |
| Net loss per common share | |
| Basic | |
| Diluted | |
| Weighted-average common shares outstanding | |
| Basic | |
| Diluted |
Loading...
